Discover

GRI
GRI Bio, Inc.
1.78
1 x 2.22
1 x 2.28
bid
ask
+
0.03
1.71%
1 @ 06:22 AM
1.92 +0.14 (7.87%)
Ytd-74.28%
1y-95.36%
1.70
day range
1.84
1.70
52 week range
80.36
Open1.75Prev Close1.75Low1.70High1.84Mkt Cap3.15M
Vol45.94KAvg Vol107.52KEPS38.89P/E0.05Forward P/E-0.29
BetaN/AShort Ratio0.10Inst. Own4.71%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg2.15200-d Avg18.911yr Est11.50
Income Statement
Operating Expenses2.00M
Research and Development Expense361.00K
Selling, General and Administrative Expense1.64M
Operating Income-2.00M
Net Income-2.00M
Net Income Common Stock-2.00M
Net Income Common Stock (USD)-2.00M
Consolidated Income-2.00M
Earnings per Basic Share-1.61
Earnings per Basic Share (USD)-1.61
Earnings per Diluted Share-1.61
Earning Before Interest & Taxes (EBIT)-2.00M
Earning Before Interest & Taxes (USD)-2.00M
Weighted Average Shares1.24M
Weighted Average Shares Diluted1.24M
Balance Sheet
Cash and Equivalents11.05M
Cash and Equivalents (USD)11.05M
Current Assets11.28M
Property, Plant & Equipment Net60.00K
Total Assets11.34M
Debt Current58.00K
Total Debt58.00K
Current Liabilities794.00K
Total Liabilities794.00K
Accumulated Retained Earnings (Deficit)-53.69M
Shareholders Equity10.55M
Shareholders Equity (USD)10.55M
Assets Non-Current60.00K
Total Debt (USD)58.00K
Trade and Non-Trade Payables303.00K
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow from Financing6.50M
Net Cash Flow / Change in Cash & Cash Equivalents2.82M
Issuance (Purchase) of Equity Shares6.50M
Net Cash Flow from Operations-3.68M
Share Based Compensation31.00K